Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

for
Solid Tumors, Non Small Cell Lung Cancer,
Location: New Haven CT
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT06205706

Phase 1, Phase 2, Recruiting

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

for
Cancer, Period Problem
Location: Commack NY, Rockville Centre NY, East White Plains NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 15 - 40

Code: NCT06915116

Phase 2, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Providence RI, Mineola NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase 1, Recruiting

Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning

for
Malignant Solid Neoplasm,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 0+

Code: NCT06200116

Recruiting

Cisplatin Induced Kidney Toxicity

for
Acute Kidney Injury, Cancer
Location: London
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0+

Code: NCT04442516

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

for
Advanced EGFR Positive Solid Tumor
Location: The Bronx NY, Fairway KS, Los Angeles CA
Sponsor: Changchun Intellicrown Pharmaceutical Co. LTD

Sex: All

Age: 18+

Code: NCT04412616

Phase 1, Recruiting

Massage Impact on Sleep in Pediatric Oncology

for
Cancer, Pediatric Cancer, Chemotherapy Effect,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 12 - 21

Code: NCT06892158

Recruiting

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

for
Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT04358913

Recruiting

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

for
Cancer
Location: Saint John, Montreal, Ottawa, Toronto, Hamilton,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03847649

Phase 2, Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: New York NY, Newark DE, Baltimore MD, Bethesda MD,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase 1, Recruiting

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

for
Neoplasms, Arteriovenous Malformation of Central Nervous System,
Location: Miami FL, Detroit MI
Sponsor: The Radiosurgery Society

Sex: All

Age: 0+

Code: NCT01885299

Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18 - 70+

Code: NCT04333706

Phase 1, Phase 2, Recruiting

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Baltimore MD, Whittier CA, Los Angeles CA
Sponsor: Zhejiang Haichang Biotech Co., Ltd.

Sex: All

Age: 18+

Code: NCT05267899

Phase 1, Recruiting

Active Living After Cancer: Implementation Within Be Well Acres Homes

for
Cancer, Fatigue
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06907706

Recruiting

HP Pyruvate MRI in Cancers

for
Image, Warburg Effect, Tumors
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT05697406

Phase 1, Phase 2, Recruiting

Childhood Cancer Predisposition Study (CCPS)

for
Pediatric Cancer
Location: Boston MA, Philadelphia PA, Toronto, Atlanta GA,
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT04511806

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

for
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma
Location: Port Saint Lucie FL, Huntersville NC, Greenville SC,
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT05892718

Phase 1, Recruiting

Lorlatinib Combinations in Lung Cancer

for
Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04292119

Phase 1, Phase 2, Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Hollywood FL, Athens GA, Columbus OH,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT03093116

Phase 1, Phase 2, Recruiting

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

for
Refractory and/or Relapsed Metastatic Solid Tumors
Location: Valhalla NY, The Bronx NY, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 1 - 50

Code: NCT01804634

Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial